Pay in 4 interest-free payments of $6.27 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
An older clinical trial compared treatment with 3.0 mg of liraglutide to a placebo
Looking ahead, the pipeline war will likely shift from GLP-1-centric models to whatever comes next (gene therapy
Large trials showed benefits that extended beyond weight alone
Tirzepatide and Ozempic (Semaglutide) are both GLP-1 receptor agonists for type 2 diabetes and obesity but they are not the same
Zepbound, approved in 2023, had similar persistence rates
However, driven by shifts in dietary patterns and rising obesity rates, its incidence and prevalence are steadily increasing, with the disease increasingly manifesting in younger individuals (1)
US$ 22.22
US$ 26.88
US$ 28.31
US$ 27.10
US$ 21.38
US$ 26.36
US$ 24.44
US$ 25.22
